Zusammenfassung
Die Einführung des zytologischen Screenings hat zu einer sinkenden Inzidenz des Zervixkarzinoms in Deutschland geführt, und es besteht die begründete Hoffnung, dass die HPV-Impfung zu einem weiteren Rückgang führen wird. Auch für die primäre Behandlung von Patientinnen mit manifestem Karzinom haben sich in den letzten Jahren technische und konzeptionelle Neuerungen ergeben. Hier vorgestellt werden aktuelle Vorgehensweisen in Diagnostik und Therapie, diskutiert werden die Beiträge von Magnetresonanz- (MRT) und Positronenemissionstomographie (PET) zum prätherapeutischen Staging und minimal-invasive Techniken zur Reduktion des operativen Traumas. Die totale mesometriale Resektion (TMMR) ist eine neue, kontrovers diskutierte chirurgische Technik, die auf einem Tumorausbreitungsmodell innerhalb morphogenetischer Einheiten basiert. Die ersten Daten deuten darauf hin, dass die TMMR in Kombination mit der therapeutischen Lymphonodektomie auch in Fällen mit histopathologischen Risikofaktoren lokale und regionale Tumorkontrolle gewährleistet.
Abstract
The introduction of cytological screening has led to a reduction in the incidence of cervical cancer in Germany and there is reason to hope that human papillomavirus (HPV) inoculation will lead to a further reduction. In recent years there have also been technical and conceptual improvements even for the primary treatment of patients with manifest cancer. This article presents the current approaches in diagnostics and therapy and the contribution of magnetic resonance imaging (MRI) and positron emission tomography (PET) for pretherapeutic staging and minimally invasive techniques for reduction of operative trauma will be discussed. Total mesometrial resection (TMMR) is a new but controversial surgical technique based on a tumor spread model within morphological entities. Initial data indicate that TMMR in combination with therapeutic lymphadenectomy guarantees local and regional control even in cases with histopathological risk factors.
Literatur
Altgassen C, Hertel H, Brandstadt A et al (2008) Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 26(18):2943–2951
Belhocine T, Thille A, Fridman V et al (2002) Contribution of whole-body 18FDG PET imaging in the management of cervical cancer. Gynecol Oncol 87(1):90–97
Benedet JL, Bender H, Jones H III et al (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70(2):209–262
Berman ML, Lagasse LD, Watring WG et al (1977) The operative evaluation of patients with cervical carcinoma by an extraperitoneal approach. Obstet Gynecol 50(6):658–664
Bezu C, Coutant C, Ballester M et al (2010) Ultrastaging of lymph node in uterine cancers. J Exp Clin Cancer Res 29:5
Boggess JF, Gehrig PA, Cantrell L et al (2008) A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy. Am J Obstet Gynecol 199(4):357
Brockbank E, Kokka F, Bryant A et al (2011) Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer. Cochrane Database Syst Rev 4:CD008217
Childers JM, Hatch KD, Tran AN, Surwit EA (1993) Laparoscopic para-aortic lymphadenectomy in gynecologic malignancies. Obstet Gynecol 82(5):741–747
Dargent D (1987) A new future for Schauta’s operation through a presurgical retroperitoneal pelviscopy. Eur J Gynaecol Oncol (8):292–296
Dargent D, Salvat J (1989) Envahissenent ganglionnaire pelvien: place de la pelviscopie retroperitoneale. Medsi, McGraw-Hill, Paris
Fanning J, Fenton B, Purohit M (2008) Robotic radical hysterectomy. Am J Obstet Gynecol 198(6):649
Ferlay J, Shin HR, Bray F et al (2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. International Agency for Research on Cancer IARC, Geneva
Hauspy J, Beiner M, Harley I et al (2007) Sentinel lymph nodes in early stage cervical cancer. Gynecol Oncol 105(2):285–290
Hertel H, Kohler C, Michels W et al (2003) Laparoscopic-assisted radical vaginal hysterectomy (LARVH): prospective evaluation of 200 patients with cervical cancer. Gynecol Oncol 90(3):505–511
Hillemanns P, Höß C, Kürzl R (2004) Zervixkarzinom. Manual des Tumorzentrums München (3)
Hockel M, Horn LC, Fritsch H (2005) Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol 6(10):751–756
Hockel M, Horn LC, Manthey N et al (2009) Resection of the embryologically defined uterovaginal (Mullerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol 10(7):683–692
Hricak H, Gatsonis C, Chi DS et al (2005) Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 23(36):9329–9337
Kruijdenberg CB, Einden LC van den, Hendriks JC et al (2011) Robot-assisted versus total laparoscopic radical hysterectomy in early cervical cancer, a review. Gynecol Oncol 120(3):334–339
Lagasse LD, Creasman WT, Shingleton HM et al (1980) Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol 9(1):90–98
Lai CH, Huang KG, Hong JH et al (2003) Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol 89(1):160–167
Landoni F, Maneo A, Cormio G et al (2001) Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol 80(1):3–12
LaPolla JP, Schlaerth JB, Gaddis O, Morrow CP (1986) The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol Oncol 24(2):194–206
Magrina JF, Zanagnolo VL (2008) Robotic surgery for cervical cancer. Yonsei Med J 49(6):879–885
Mitchell DG, Snyder B, Coakley F et al (2006) Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol 24(36):5687–5694
Nezhat FR, Datta MS, Liu C et al (2008) Robotic radical hysterectomy versus total laparoscopic radical hysterectomy with pelvic lymphadenectomy for treatment of early cervical cancer. JSLS 12(3):227–237
Park A, Lee G, Seagull FJ et al (2010) Patients benefit while surgeons suffer: an impending epidemic. J Am Coll Surg 210(3):306–313
Robert K (2010) I. Krebs in Deutschland 2005/2006 Häufigkeiten und Trends. Robert Koch Institut (60)
Rose PG, Adler LP, Rodriguez M et al (1999) Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 17(1):41–45
Schneider A, Possover M, Kamprath S et al (1996) Laparoscopy-assisted radical vaginal hysterectomy modified according to Schauta-Stoeckel. Obstet Gynecol 88(6):1057–1060
Tsai CS, Lai CH, Chang TC et al (2010) A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy. Int J Radiat Oncol Biol Phys 76(2):477–484
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fleisch, M., Scholz, C., Rein, D. et al. Zervixkarzinom. Gynäkologe 44, 694–700 (2011). https://doi.org/10.1007/s00129-011-2768-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-011-2768-9
Schlüsselwörter
- Humane Papillomviren
- Totale mesometriale Resektion
- Minimal-invasive Chirurgie
- Sentinel-Lymphknoten
- Roboterassistierte Chirurgie